Mark G Sandbaken, ATY - Seattle Genetics Inc
Seagen, now part of Pfizer, is a global biotechnology company headquartered in Bothell, WA, dedicated to revolutionizing cancer care through the development of transformative therapies that significantly impact patients' lives. With a focus on antibody-drug conjugates (ADCs), Seagen has been at the forefront of innovative cancer therapeutics for over two decades, committed to addressing challenging clinical needs with safe and effective solutions.
Driven by a mission to make a tangible difference for individuals affected by cancer, Seagen's research efforts are centered on advancing a diverse pipeline of novel therapies for both solid tumors and blood-related cancers. The company's culture emphasizes integrity, collaboration, and diversity, uniting a global team of scientists, clinicians, advocates, and innovators in the shared goal of transforming cancer care and supporting patients and their families throughout their journey.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
